Cargando…
Oridonin attenuates low shear stress-induced endothelial cell dysfunction and oxidative stress by activating the nuclear factor erythroid 2-related factor 2 pathway
BACKGROUND: Atherosclerosis (AS) is the primary cause of cardiovascular disease and the incidence is extremely common; however, there are currently few drugs that can effectively treat AS. Although oridonin has been widely used to treat inflammation and cancer for numerous years, to the best of our...
Autores principales: | Chen, Zhipeng, Liu, Heqian, Zhao, Xiaoqi, Mamateli, Subinur, Liu, Cheng, Wang, Lei, Yu, Jing, Liu, Yutong, Cai, Jing, Qiao, Tong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9261036/ https://www.ncbi.nlm.nih.gov/pubmed/35799227 http://dx.doi.org/10.1186/s12906-022-03658-2 |
Ejemplares similares
-
Oridonin attenuates the progression of atherosclerosis by inhibiting NLRP3 and activating Nrf2 in apolipoprotein E-deficient mice
por: Wang, Lei, et al.
Publicado: (2023) -
Risk factors for target vessel endoleaks after physician-modified fenestrated or branched endovascular aortic arch repair: A retrospective study
por: Chen, Zhipeng, et al.
Publicado: (2023) -
Inflammatory response and oxidative stress attenuated by sulfiredoxin-1 in neuron-like cells depends on nuclear factor erythroid-2-related factor 2
por: Wu, Zhiliang, et al.
Publicado: (2020) -
Oridonin prevents oxidative stress‐induced endothelial injury via promoting Nrf‐2 pathway in ischaemic stroke
por: Li, Lei, et al.
Publicado: (2021) -
Relationship between oxidative stress and nuclear factor-erythroid-2-related factor 2 signaling in diabetic cardiomyopathy (Review)
por: Wu, Xia, et al.
Publicado: (2021)